Cheelcare Invited to Numotion Commercial Growth Summit

Rhea-AI Summary

Cheelcare (TSXV: CHER, OTC: CHCRF) announced it has been invited to present at the Numotion Commercial Growth Summit, held August 12-14, 2026 in Denver, Colorado. The event gathers clinicians, Assistive Technology Professionals, regional decision-makers and industry leaders across Numotion's network.

Cheelcare will showcase its Companion power assist attachment for manual wheelchairs, featuring patented QuickConnect technology and PDAC verification supporting U.S. Medicare and Medicaid reimbursement eligibility. Companion has been named Mobility Management magazine's Product of the Year for three consecutive years. Management views participation as aligned with its strategy to raise awareness among key mobility providers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Markham, Ontario--(Newsfile Corp. - August 6, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that it has been invited to participate in the Numotion Commercial Growth Summit, scheduled for August 12-14, 2026, in Denver, Colorado.

The Commercial Growth Summit brings together clinicians, Assistive Technology Professionals (ATP's), regional decision-makers, and industry leaders from across Numotion's network to evaluate mobility technologies, share clinical best practices, and discuss innovations that improve outcomes for wheelchair users. Management believes the invitation reflects Cheelcare's growing recognition among leading mobility providers in North America and provides an opportunity to strengthen relationships with key stakeholders who influence product selection.

Numotion is North America's largest provider of Complex Rehab Technology and mobility solutions, serving more than 500,000 customers annually through a network of over 196 locations across the United States and Canada. Management believes participation in the Summit supports the Company's strategy of increasing awareness of its mobility solutions among clinicians, providers, and decision-makers throughout Numotion's network.

At the Summit, Cheelcare will present its Companion power assist attachment, a powerful, highly configurable solution that gives manual wheelchair users the freedom to go farther with less physical strain. The device features patented QuickConnect technology and PDAC verification supporting reimbursement eligibility under U.S. Medicare and Medicaid, Companion has been recognized by Mobility Management magazine as Product of the Year for three consecutive years.

"Being invited to present at Numotion's Commercial Growth Summit reflects the relationships we have built with one of North America's leading mobility providers," said Allan Boyd, Vice President of Growth, Cheelcare. "Our strategy has been to establish strong clinical credibility and let commercial relationships follow, and this invitation is a direct result of that approach. Beyond showcasing Companion, the Summit provides an opportunity to deepen our relationship across Numotion's network as we continue expanding our portfolio of mobility solutions, including the commercialization of Curio and future innovations designed to improve independence and quality of life for wheelchair users."

About Cheelcare Inc.

Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic complex-rehab power wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life. For more information, please visit: www.cheelcare.ca.

For further information, please contact:

Sofiya Kagan, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x 206
Email: skagan@cheelcare.com

Forward-Looking Information:

This news release may contain forward-looking statements. Forward-looking statements are based on current expectations and involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those expressed or implied. Such factors include, but are not limited to, general economic conditions, market demand, supply chain disruptions, and regulatory approvals. Any forward-looking statements are made as of the date of this news release, and the Company does not undertake to update any forward-looking statements except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308108

FAQ

What is the Numotion Commercial Growth Summit that Cheelcare (OTC: CHCRF) will attend in August 2026?

The Numotion Commercial Growth Summit is a Numotion-hosted event gathering clinicians, Assistive Technology Professionals, decision-makers and industry leaders. According to Cheelcare, the 2026 summit in Denver will focus on evaluating mobility technologies, sharing clinical best practices and discussing innovations for wheelchair users.

When and where will Cheelcare (CHCRF) present at the Numotion Commercial Growth Summit 2026?

Cheelcare is scheduled to participate in the Numotion Commercial Growth Summit from August 12-14, 2026, in Denver, Colorado. According to Cheelcare, company representatives will present the Companion power assist attachment to clinicians and decision-makers across Numotion’s North American network.

What product will Cheelcare (CHCRF) showcase at the Numotion summit, and what does it do?

Cheelcare will showcase its Companion power assist attachment for manual wheelchairs. According to Cheelcare, Companion is a powerful, configurable device that helps users travel farther with less physical strain, using patented QuickConnect technology to enhance mobility and independence.

Is Cheelcare’s Companion device presented at Numotion eligible for Medicare and Medicaid reimbursement?

Cheelcare states that its Companion power assist attachment has PDAC verification, supporting reimbursement eligibility under U.S. Medicare and Medicaid. According to Cheelcare, this verification helps position Companion within funded mobility solutions for eligible manual wheelchair users in the United States.

Why is Cheelcare’s invitation to the Numotion Commercial Growth Summit important for CHCRF investors?

The invitation gives Cheelcare direct exposure to clinicians and decision-makers within Numotion’s extensive network. According to Cheelcare, management believes participation supports its strategy of increasing awareness and strengthening relationships with leading North American mobility providers that influence product selection.

How has Cheelcare’s Companion device been recognized in the mobility industry?

Cheelcare reports that its Companion power assist attachment has been recognized by Mobility Management magazine as Product of the Year for three consecutive years. According to Cheelcare, this industry recognition supports its focus on clinically credible, innovative mobility solutions for wheelchair users.

What other mobility solutions, besides Companion, is Cheelcare (CHCRF) developing?

Alongside Companion, Cheelcare is working on the commercialization of its Curio robotic complex-rehab power wheelchair. According to Cheelcare, Curio and future innovations are designed to improve independence and quality of life for people with disabilities and wheelchair users.